Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, February 24, 2010

Intraperitoneal Paclitaxel as Consolidation Treatment in Ovarian Cancer Patients: A Case Control Study

Conclusion: Weekly IP consolidation chemotherapy with paclitaxel 60 mg/mq is well tolerated and, in this experience, a prolongation of progression-free survival was observed.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.